SHSE:603334 (China)
Â
Ordinary Shares - Class A
Â¥
29.84
-0.82 (-2.67%)
Sep 11
Business Description
Suzhou Fengbei Biotech Stock Co Ltd
ISIN : CNE100007D25
Share Class Description:
SHSE:603334: Ordinary Shares - Class ATotal Employee Number:
395Compare
Compare
Traded in other countries / regions
603334.China IPO Date
2025-11-05Description
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.87 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 1.46 | |||||
Interest Coverage | 33.59 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 8.02 | |||||
Beneish M-Score | -4.34 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.1 | |||||
3-Year EBITDA Growth Rate | 0.9 | |||||
3-Year EPS without NRI Growth Rate | -2.2 | |||||
3-Year FCF Growth Rate | -66 | |||||
3-Year Book Growth Rate | 35.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.31 | |||||
9-Day RSI | 33.39 | |||||
14-Day RSI | 37.49 | |||||
3-1 Month Momentum % | -14.7 | |||||
6-1 Month Momentum % | -37.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.46 | |||||
Quick Ratio | 2.52 | |||||
Cash Ratio | 1.33 | |||||
Days Inventory | 40.15 | |||||
Days Sales Outstanding | 19.43 | |||||
Days Payable | 15.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.17 | |||||
Dividend Payout Ratio | 0.31 | |||||
Forward Dividend Yield % | 1.17 | |||||
5-Year Yield-on-Cost % | 1.17 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | 2.95 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 6.71 | |||||
Operating Margin % | 4.52 | |||||
Net Margin % | 3.39 | |||||
EBITDA Margin % | 3.92 | |||||
FCF Margin % | -3.84 | |||||
OCF Margin % | -3.01 | |||||
ROE % | 9.94 | |||||
ROA % | 7.24 | |||||
ROIC % | 13.97 | |||||
3-Year ROIIC % | 2.26 | |||||
ROC (Joel Greenblatt) % | 17.23 | |||||
ROCE % | 11.05 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.25 | |||||
PE Ratio without NRI | 26.6 | |||||
PEG Ratio | 1.64 | |||||
PS Ratio | 0.97 | |||||
PB Ratio | 2.48 | |||||
Price-to-Tangible-Book | 2.57 | |||||
EV-to-EBIT | 24.33 | |||||
EV-to-EBITDA | 24.33 | |||||
EV-to-Revenue | 0.95 | |||||
EV-to-FCF | -24.83 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.53 | |||||
Price-to-Graham-Number | 1.74 | |||||
| Price-to-Net-Current-Asset-Value | 3.54 | |||||
| Price-to-Net-Cash | 29.25 | |||||
Earnings Yield (Greenblatt) % | 4.11 | |||||
FCF Yield % | -3.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Suzhou Fengbei Biotech Stock Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,039.404 | ||
| EPS (TTM) (Â¥) | 1.02 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 37.49 | ||
| 14-Day ATR (Â¥) | 1.163902 | ||
| 20-Day SMA (Â¥) | 32.0735 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (Â¥) | 29.6 - 76 | ||
| Shares Outstanding (Mil) | 143.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Suzhou Fengbei Biotech Stock Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Suzhou Fengbei Biotech Stock Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.350000 Cash Dividend | 2026-06-08 | 41.66 (-2.57%) |
Show
Entries
Suzhou Fengbei Biotech Stock Co Ltd Frequently Asked Questions
What is Suzhou Fengbei Biotech Stock Co Ltd(SHSE:603334)'s stock price today?
The current price of SHSE:603334 is ¥29.84. The 52 week high of SHSE:603334 is ¥76.00 and 52 week low is ¥29.60.
When is next earnings date of Suzhou Fengbei Biotech Stock Co Ltd(SHSE:603334)?
The next earnings date of Suzhou Fengbei Biotech Stock Co Ltd(SHSE:603334) is .
Does Suzhou Fengbei Biotech Stock Co Ltd(SHSE:603334) pay dividends? If so, how much?
The Dividend Yield %  of Suzhou Fengbei Biotech Stock Co Ltd(SHSE:603334) is 1.17% (As of Today), Highest Dividend Payout Ratio of Suzhou Fengbei Biotech Stock Co Ltd(SHSE:603334) was 0.31. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Suzhou Fengbei Biotech Stock Co Ltd(SHSE:603334) is 1.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers